Literature DB >> 33402887

Bacteriospermia, extended spectrum beta lactamase producing Gram-negative bacteria and other factors associated with male infertility in Mwanza, Tanzania: a need of diagnostic bacteriology for management of male infertility.

Vitus Silago1, Yusuph Mukama1, Anna L Haule1, Frank Chacha2, John Igenge2, Martha F Mushi1, Stephen E Mshana1.   

Abstract

BACKGROUND: Infections caused by Extended spectrum beta lactamase (ESBL) producing bacterial are global challenge. There is limited information on the magnitude of bacteriospermia, ESBL producing Gram-negative bacteria (GNB) causing bacteriospermia and factors associated with male infertility. This study determined magnitude of bacteriospermia, ESBL-GNB and other factors association with infertility among presumptive infertile men in Mwanza, Tanzania.
METHODS: A cross-sectional hospital-based study was conducted between May 2017 and July 2018 among 137 presumptive infertile men. Semen specimens were self-collected by masturbation into clean, sterile and none-spermicidal containers and processed following laboratory standard operating procedures (SOPs). Data analysis was done using STATA 13.0.
RESULTS: Gram-negative bacteria were predominantly isolated (86.4%), of which 31.6% were ESBL producers. In a total 44 bacteria were isolated from semen culture. The blaCTX-M gene was detected in 75% of phenotypically confirmed ESBL producers. Infertility was independently found to be associated with abnormal spermatozoa morphology (OR (95%CI): 14.48(3.17-66.05)) and abnormal spermatozoa motility (OR (95%CI): 0.05(0.01-0.24)). However, neither bacteriospermia (OR (95%CI): 0.86(0.29-2.59)) nor ESBL bacteriospermia (OR (95%CI): 0.13(0.01-1.22)) was found to be associated with infertility.
CONCLUSION: One third of bacteriospermia is due to ESBL-producers with history of antibiotic use being protective factor for infertility. Abnormal spermatozoa morphology and poor spermatozoa forward motility independently predicted infertility.
© 2020 Silago V et al.

Entities:  

Keywords:  Mwanza; Tanzania; bacteriospermia; blaCTX-M; extended spectrum beta lactamase; male infertility

Mesh:

Substances:

Year:  2020        PMID: 33402887      PMCID: PMC7750055          DOI: 10.4314/ahs.v20i1.4

Source DB:  PubMed          Journal:  Afr Health Sci        ISSN: 1680-6905            Impact factor:   0.927


Introduction

Bacteria, fungi, protozoa and viruses are agents implicated in male urogenital tract and accessory sex gland infections and account for about 15% of male infertility1,2. Bacteria like; Staphylococcus aureus, Enterococcus faecalis, Staphylococcus saprophyticus, Escherichia coli, Pseudomonas aeruginosa and Klebsiella pneumoniae are the most common pathogens reported to be isolated from semen culture and causing bacteriospermia3,4. Bacteriospermia has been found to cause infertility due to various factors such as: deterioration of spermatogenesis, alteration of acrosome and sperm morphology, auto-immune processes induced by inflammation, increased sperm DNA fragmentation due to formation of reactive oxygen species and obstruction of genital tracts due to fibrosis and inflammation3,5. Production of Extended spectrum beta lactamase (ESBL) among multi-drug resistant (MDR) Gram-negative bacteria is the common antibiotic resistance mechanism6. E. coli, K. pneumoniae, Citrobacter spp., Enterobacter spp., Acinetobacter spp. and Pseudomonas aeruginosa are common ESBL producing Gram-negative bacteria (GNB)6,7. The blaCTX-M gene is documented to account over 75% of ESBL producing gram negative bacteria clinically isolated however little is known on its prevalence among ESBL producing Gram-negative bacteria causing bacteriospermia8. Here in, we report the magnitude of bacteriospermia, blaCTX-M among ESBL producing Gram-negative bacteria and other factors associated with male infertility in Mwanza, Tanzania. This is the first study to report magnitude of bacteriospermia, ESBL producing GNB and other factors associated with male infertility from Tanzania. These data are important in the management of bacteriospermia in our setting where there is high prevalence of ESBL producing Gram-negative bacteria9–11.

Methods

Study design, duration, population and setting

This cross-sectional hospital-based study was conducted between May 2017 and July 2018 involving 137 presumptive infertile men (whose female couples were medically confirmed fertile) attending reproductive health/infertility clinics in Mwanza, Tanzania. Standardized data collection tools used to collect socio-demographic and clinical characteristics of the study participants. Semen specimens were self-collected by masturbation into wide mouth, clean, sterile and spermatozoa non-toxic specimen containers (Hunter Scientific Limited, UK) after consented voluntarily and sexual abstinence of a minimum of 3 days. Patients were instructed to pass urine and then thoroughly cleaned their hands and penis with clean water and non-antiseptic soap12. Specimens were brought to Central Pathology Laboratory, department of Histopathology at the Bugando Medical Centre (BMC) for semen analysis at room temperature within 30 minutes after collection and Catholic University of Health and Allied Sciences (CUHAS) multipurpose laboratory in cold box (2–8°C) for semen culture within one hour of collection. PCR to detect blaCTX-M gene was done at National Institute of Medical Research (NIMR), Mwanza. In this study, presumptive male infertility refers to male's inability to make fertile female partner pregnant for a period of ≥ 1 year of active sexual practices without protections while medically confirmed infertility among men refers male infertility13–15. Male infertility can be medically confirmed by examining spermatozoa quality and quantity in an ejaculate13,14. This includes: spermatozoa concentration, morphology and/or forward motility13,14.

Semen analysis, culture and identification of significant isolated bacteria

Semen analysis involved the following parameters; colour (grey to opalescent), volume (2–6 ml), viscosity (< 2 cm dropping threads from pipette), pH (7.2–8.2), motility, morphology and spermatozoa count (20–120 million/milliliter) per SOPs and WHO guidelines12. Semen analysis was performed by skilled and experienced laboratory scientist (> 5 working years) and two other laboratory technicians (> 3 working years) were used to confirm for the validity of the results. Semen specimens were inoculated onto blood agar (BA) and MacConkey agar (MCA) plates followed by aerobic incubation at 37°C for 24–48 hours. A pure significant growth (≥ 103 CFU/ml growth) of bacteria were further identified to species level by inhouse biochemical identification tests; Gram stain, catalase, slide coagulase, novobiocin, bacitracin, bile esculin and optochin for Gram-positive bacteria and Gram stain, triple sugar iron (TSI), sulfur indole motility (SIM), Simmons citrate, urease and oxidase for Gram-negative bacteria16.

Antibiotic susceptibility testing

Antibiotic susceptibility testing (AST) was performed on Muller Hinton agar (MHA) plates by Kirby-Bauer disc diffusion method as per CLSI:2010 guidelines17. Erythromycin 15µg, clindamycin 2µg, vancomycin 30µg, gentamicin 10µg, cefoxitin 30µg (for S. aureus only) and ciprofloxacin 5µg were used for gram positive bacteria while ampicillin 10µg, sulphamethoxazole-trimethoprim 1.25/23.75µg, gentamicin 10µg, ciprofloxacin 5µg, amoxycillin-clavulanic acid 20/10µg, ceftriaxone 30µg, ceftazidime 30µg, piperacillin-tazobactam 100/10µg and meropenem 10µg were used for gram negative bacteria.

Phenotypic detection of ESBL producing gram negative bacteria

Double disc synergy (DDS) technique was used to detect ESBL producing gram negative bacteria as reported previously17. Briefly, ceftazidime-clavulanic acid and ceftazidime plain discs were seeded on MHA plate with test organisms. The plates were incubated for 24 hours at 37°C. The difference of zones of inhibitions of ≥ 5mm between ceftazidime-clavulanic acid and ceftazidime plain was interpreted as ESBL producer18,19.

Molecular characterization of blaCTX-M gene from ESBL producing gram negative bacteria

Heat treatment technique was performed to extract bacterial DNA with minor modification from previous study20. Two colonies of fresh grown bacteria were suspended into DNase/RNase free tubes containing 500 µL of sterile de-ionized water, mixed by vortexing and boiled at 100°C for 10 minutes. Tubes were centrifuged at 12000 rpm for 10 minutes to obtain 5 µL of supernatant of each test bacteria for PCR. PCR was performed for phenotypically confirmed ESBL producing gram negative bacteria to determine the presence of blaCTX-M gene as previously reported21. CTX-M3G; forward primer: 5′-GTTACAATGTGTGAGAAGCAG-3′ and reverse primer: 5′-CCGTTTCCGCTATTACAAAC-3′ were used. Briefly, PCR amplification was carried on thermocycler machine (GeneAmp® PCR System 9700, ThermoFishers Scientific, Singapore) as previously explained. Briefly, PCR were conditioned at; initial denaturation at 94°C for 5 minutes and cycles: 1; denaturation at 94°C for 60 seconds, 2; annealing at 55°C for 30 seconds and 3; extension at 72°C for 60 seconds and final extension at 72°C for 5 minutes. PCR products were visualized under UV illumination on gel electrophoresis by using 2% agarose gel stained with redsafe (7.5 µL of redafe were added into 150 ml of TBE suspended with 3g of agarose powder). The amplicon with band size of 1000bp was annotated as blaCTX-M gene, (Figure 1). E. coli ATCC 25922 was used as negative control organisms.
Figure 1

Visualization of PCR products on 2% agarose gel stained with redsafe. Lane M; ladder marker and lanes 1–13; phenotypic confirmed bacterial isolates. Bacteria with positive blaCTX-M genes are shown by black arrows while negative are shown with with thick blue arrows.

Visualization of PCR products on 2% agarose gel stained with redsafe. Lane M; ladder marker and lanes 1–13; phenotypic confirmed bacterial isolates. Bacteria with positive blaCTX-M genes are shown by black arrows while negative are shown with with thick blue arrows.

Statistical analysis

Data analysis was done by using STATA 13.0 version. Continuous data were presented as mean (± SD) and categorical data as percentages. Logistic regression analysis was used to show association between male infertility and independent variables. A p-value of less than 0.05 at 95% confidence interval was considered as statistically significant.

Ethical considerations

Ethical clearance to conduct this study was obtained from a joint BMC/CUHAS ethics and review committee and given ethical numbers: CREC 329/2017 and updated in 2018 by certificate number 719/2018. Written informed consent forms were obtained from study participants before enrollment in this study. Laboratory results; semen analysis, and culture and sensitivity were submitted to respective clinicians for patient management

Results

Socio-demographic and clinical characteristics of study participants

A total of 137 participants were enrolled during this study period. The mean age (±SD) and mean infertility duration (±SD) was 33±6.9 years and 2.7±2 years, respectively. The majorities of participants were living in urban areas (64.2%), 54.0% had tertiary education and 97.1% enrolled from BMC. The following participants reported history of; 2.2% fever, 16.1% antibiotic use within one month prior to enrollment in this study, 18.3% UTI and 3.7% sexually transmitted diseases (STDs). Of the 22 participants with history of antibiotic use, 13 used for ≤ 5 days while of 25 participants with history of UTI, 7 purchased antibiotic without prescription, (Table 1).
Table 1

Socio-demographic and clinical characteristics of study participants

VariablesFrequency (n)Percentage (%)
Mean (+/− SD) age (years)33 (+/− 6.9)-

Mean (+/−SD) infertility duration (years)2.7 (+/− 2)-

Residence (N=137)Urban8864.2
Rural4935.8

Level of education (N=137)Uneducated32.2
Primary107.3
Secondary5036.5
Tertiary7454.0

Recruitment clinic (N=137)Bugando Medical Centre13397.1
Kamanga Hospital21.4
Manjis health care centre21.4

History of fever (N=137)Yes32.2
No13497.8

Previous antibiotic (N=137)Yes2216.1
No11583.9

Duration of antibiotic use (N=22)≤ 5 days1359.1
1 week29.1
2 weeks627.3
1 month14.5

Type of antibiotic used (N=22)Ceftriaxone940.9
Ciprofloxacin836.4
Azythromycin313.6
Cotrimoxazole14.5
Amoxycillin14.5

History of UTI (N=137)Yes2518.3
No11281.7

UTI treatment facility (N=25)Healthcare facility1872
Pharmacy or drug shops728

History of STD (N=137)Yes53.7
No13296.3

STD treatment (N=137)Complete480
Incomplete120

Catheterization (N=137)Yes10.7
No13699.3

Other co-morbid (N=137)Yes (Hypertension)10.7
No13699.3
Socio-demographic and clinical characteristics of study participants

Semen analysis, bacteriospermia and ESBL bacteriospermia

All participants (100%) had normal semen appearance (color) during semen analysis. Of 137 studied participants, majority of participants had abnormal semen volume (63.5%): 92.0% hypospermia and 8.0% hyperspermia, and poor forward motility of spermatozoa 63.5%. Infertility was observed among 35.0% of participants of which 64.6% had oligospermia (Table 2).
Table 2

Semen analysis, bacteriospermia and ESBL bacteriospermia results

VariablesFrequency (n)Percentage (%)
Quality of spermatozoa and semen

Semen appearance (N=137)Normal137100
Poor00

Semen PH (N=137)Normal (7.2 – 8.2)13195.6
Increased alkaline (≥ 9)64.4

Semen viscosity (N=137)Normal5540.1
Abnormal8259.9

Semen volume (N=137)Normal5036.5
Abnormal8763.5

Abnormal semen volume (N=87)Hypospermia8092.0
Hyperspermia78.0

Spermatozoa morphology (N=137)Normal11583.9
Abnormal2216.1

Spermatozoa motility (N=137)Good forward motility5036.5
Poor forward motility8763.5

Quantity of spermatozoa in semen

Male infertility (N=137)Normalspermia8965.0
Infertility4835.0

Infertility types (N=48)Oligospermia(<20 mil/ml)3164.6
Azoospermia (no sperms)1633.3
Necrospermia (dead)12.1

Bacteriospermia

Bacteriospermia (N=137)Positive4432.1
Negative9367.9

Isolated bacteria spp (N=44)K. pneumoniae1227.3
E. coli920.5
Acinetobacter spp715.9
Enterobacter aerogenes36.8
Enterococcus faecalis36.8
K. oxytoca36.8
P. aeruginosa36.8
Others*36.8

ESBL Bacteriospermia

ESBL producing GNB (N=38)Producers1231.6
None producers2664.8

ESBL-GNB speciesK. pneumoniae758.3
Acinetobacter spp325
Enterobacter aerogenes18.3
Pseudomonas aeruginosa18.3

ESBL blaCTX-M3G gene (N=12)Positive975
Negative325
Semen analysis, bacteriospermia and ESBL bacteriospermia results Among 137 semen culture, 32.1% had positive bacteriospermia of which Gram-negative bacteria were predominantly isolated (86.4%). K. pneumoniae (27.3%) was the most frequently isolated bacteria followed by E. coli (20.5%) and Acinetobacter spp. (15.9%). Out of 38 Gram-negative bacteria, 31.6% were phenotypically ESBL producers. K. pneumoniae was predominant ESBL producer detected (58.3%). ESBL blaCTX-M gene was found among 75% of phenotypically confirmed ESBL producers (Table 2). The mean age (±SD) and mean infertility duration from seeking medical intervention (±SD) of the 15 infertile participants with bacteriospermia was 31.5 (±8.1) years and 2.5 (±1.5) years, respectively. The majority of infertile participants with bacteriospermia had semen hyperviscosity (73.3%, n=11), hypospermia (66.7%, n=10) and poor forward spermatozoa motility (66.7%, n=10) while 4 (26.7%) participants had no spermatozoa in their semen (Table 3).
Table 3

Description of 15 infertile participants with bacteriospermia

Age (years)Infertility durationHistory of UTISemen analysisBacteria sppESBL
ViscosityVolumeMorphologyMotilityRemarks
251YesAbnormalReducedNormalNormalOligospermiaE. faecalisN/A
202NoAbnormalReducedN/AN/AAzoospermiaS. pyogenesN/A
332NoAbnormalIncreasedNormalPoorOligospermiaE. faecalisN/A
261NoAbnormalNormalNormalPoorOligospermiaE. coliNEG
323NoAbnormalIncreasedNormalPoorOligospermiaK. pneumoniaeNEG
261NoAbnormalNormalNormalPoorOligospermiaE. coliNEG
455NoNormalReducedNormalPoorOligospermiaK. pneumoniaePOS
364NoNormalReducedN/AN/AAzoospermiaK. pneumoniaePOS
355NoAbnormalReducedAbnormalPoorOligospermiaE. coliNEG
322YesAbnormalReducedNormalPoorOligospermiaK. pneumoniaeNEG
353NoNormalIncreasedAbnormalPoorOligospermiaAcinetobacter sppNEG
291NoAbnormalReducedNormalPoorOligospermiaE. coliNEG
495NoNormalReducedNormalPoorOligospermiaK. oxytocaNEG
191NoAbnormalReducedN/AN/AAzoospermiaP. aeruginosaNEG
312NoAbnormalReducedN/AN/AAzoospermiaAcinetobacter sppNEG

KEY: ID=Identification number, N/A=Not Applicable, NEG=Negative and POS=Positive

Description of 15 infertile participants with bacteriospermia KEY: ID=Identification number, N/A=Not Applicable, NEG=Negative and POS=Positive

Antibiotics resistance pattern

Percentage resistance of Gram-negative bacteria to antibiotics ampicillin, trimethoprim-sulphamethoxazole and amoxycillin-clavulanic acid was 100%, 100% and 92.1% respectively while ESBL-GNB resistance to ampicillin, trimethoprim-sulphamethoxazole, amoxycillin-clavulanic acid and gentamicin was 100%, 100%, 91.7% and 66.7%. Percentage resistances of Gram-positive bacteria to erythromycin w ere 66.7% (Table 4).
Table 4

Antibiotics susceptibility patterns of isolated bacteria causing bacteriospermia and ESBL producing GNB

ISOLATESINTANTIBIOTIC SUSCEPTIBILITY PROFILES

AMP n(%)SXT n(%)AK n(%)CIP n(%)GEN n(%)AMC n(%)CRO n(%)CAZ n(%)TZP n(%)MEM n(%)E n(%)VA n(%)CD n(%)
GNB (N=38)R38(100%)38 (100%)2(5.3%)5(13.2%)9(23.7%)35(92.1%)15(39.5%)11(28.9%)3(7.9%)-N/AN/AN/A
I--4(10.5%)1(2.6%)1(2.6%)2(5.3%)3(7.9%)5(13.2%)3(7.9%)-
S--32(84.2%)32(84.2%)28(73.7%)1(2.6%)20(52.6%)22(57.9%)32(84.2%)38(100%)
ESBL-GNB (N=12)R12(100%)12(100%)2(16.7%)2(16.7%)8(66.7)11(91.7%)10(83.3%)10(83.3%)2(16.7%)-N/A
I--1(8.3%)--1(8.3%)2(16.7%)2(16.7%)1(8.3%)-
S--9(75%)10(83.3%)4(33.3%)---9(75%)12(100%)
GPB (N=6)RN/AN/AN/A1(16.7%)2(33.3%)N/AN/AN/AN/AN/A4(66.7%)
I-1(16.7%)1(16.7%)--
S5(83.3%)3(50%)1(16.7%)6(100%)6(100%)

AMP=ampicillin, SXT=cotrimoxazole, AK=amikacin, CIP=ciprofloxacin, GEN=gentamicin, AMC=amoxycillin-clavulanic acid, CRO=ceftriaxone, CAZ=ceftazidime, TZP=piperacillin-tazobactam, MEM=meropenem, E=erythromycin, VA=vancomycin, CD=clindamycin, INT=interpretation, R=resistance, I=intermediate, S=sensitive and NA=not applicable

Antibiotics susceptibility patterns of isolated bacteria causing bacteriospermia and ESBL producing GNB AMP=ampicillin, SXT=cotrimoxazole, AK=amikacin, CIP=ciprofloxacin, GEN=gentamicin, AMC=amoxycillin-clavulanic acid, CRO=ceftriaxone, CAZ=ceftazidime, TZP=piperacillin-tazobactam, MEM=meropenem, E=erythromycin, VA=vancomycin, CD=clindamycin, INT=interpretation, R=resistance, I=intermediate, S=sensitive and NA=not applicable

Factors associated with male infertility

On Chi square analysis, male infertility was significantly associated with: semen hyper-viscosity (p=0.022), abnormal semen volume (p=0.015), abnormal spermatozoa morphology (p<0.001) and poor spermatozoa motility (p<0.001).On multivariate regression analysis, male infertility was significantly associated with: antibiotic use (OR (95%CI): 0.14(0.02–0.85),p=0.033), abnormal spermatozoa morphology (OR (95%CI): 14.48(3.17–66.05),p=0.001) and abnormal spermatozoa motility (OR (95%CI): 0.05(0.01–0.24),p<0.001). Bacteriospermia and ESBL bacteriospermia did not have significant association with infertility on both; univariate and multivariate regression analysis (Table 5).
Table 5

Factors associated with male infertility among presumptive infertile men

VariablesInfertility N=48, %Chi squareP valueMultivariate
OR(95%CI)P value
Antibiotics useYes (22)2 (9.1)7.75140.0050.14(0.02–0.85)0.033
No (115)46 (40)
History of UTIYes (25)3 (6.3)7.12990.008**
No (112)45 (93.7)
History of STDsYes (5)2 (40)0.05620.8113.39(0.33–34.82)0.304
No (132)46 (34.8)
Semen viscosityHyper (82)35 (42.6)5.24690.0221.18(0.39–3.53)0.762
Normal (55)13 (23.6)
Semen volumeAbnormal (87)37 (42.5)5.87900.0152.85(0.97–8.39)0.057
Normal (50)11 (22)
Spermatozoa morphologyAbnormal (22)19 (39.6)30.33540.00014.48(3.17–66.05)0.001
Normal (115)29 (60.4)
Spermatozoa motilityPoor (87)45 (51.7)29.16550.0000.05(0.01–0.24)0.000
Normal (50)3 (6.0)
BacteriospermiaPositive (44)15 (30.1)0.02550.5330.86(0.29–2.59)0.797
Negative (93)33 (35.5)
ESBL BacteriospermiaPositive (12)2 (16.7)1.94990.1630.13(0.01–1.22)0.073
Negative (125)46 (36.8)

had collinearity with previous history of antibiotic use

Factors associated with male infertility among presumptive infertile men had collinearity with previous history of antibiotic use

Discussion

In the current study, male infertility was found among one third of the participants, of which oligospermia was prevalent encountered type followed with azoospermia while one participant had necrospermia as observed previous22. Significantly, male infertility was associated with poor forward spermatozoa motility and abnormal spermatozoa morphology. Poor forward spermatozoa motility means that spermatozoa cannot swim properly hence unable to reach the egg for fertilization and abnormal morphology of the spermatozoa means that spermatozoa may be unable to penetrate an egg for fertilization23,24. Therefore, the two factors reduce spermatozoa quality and ability of fetilization25. These factors may be used as surrogate markers for diagnosis of male infertility14. Neither bacteriospermia nor ESBL bacteriospermia was associated with male infertility as observed elsewhere3,4. This might be due to small sample size of this study resulting to wide 95%CI and imprecise estimate of the effect therefore results didn't have statistical significance26. However, about one third of infertile men had bacteriospermia, suggesting that bacteria might have adverse impact on spermatozoa quantity and/or quality. This is further supported by the fact that history of antibiotic use was protective factor of male infertility. Therefore, there is a need of infectology to be part of infertility diagnosis and management among presumptive infertile men. Gram-negative bacteria, specifically K. pneumoniae, E. coli and Acinetobacter spp. were prevalently isolated in this study as previously reported from other studies22,27. This is contrary to a study3 which reported that, Gram-positive bacteria, specifically Enterococcus faecalis and Staphylococcus aureus were predominantly isolates causing bacteriospermia. This difference may be due to overall increase trend of multi resistant gram negative infections as the commonest cause of bacterial infections, in the current study's setting Gram-negative bacteria are the most leading causative agents of bacterial infections10. About one third of the Gram-negative bacteria were found to be ESBL producers with three quarters of phenotypic ESBL producers carrying blaCTX-M gene. The other quarter might be carrying other CTX-M groups and/or other ESBL families (SHV and TEM) as previously observed28. It should be noted previously studies21,29,30 have found blaCTX-M-15 which is a member of group 1 to be the commonest allele (>75%) in the majority of ESBL producers in Tanzania. The observation of about 30% of Gram-negative bacteria from semen culture to carry ESBL genes is significantly higher than what has been observed in other studies31,32. This could be due to high ESBL carriage in our setting due to overuse of antibiotics29,33. In this study it was observed that 16.1% of participants used antibiotics mainly cephalosporins (40.9%) without prescriptions. As previously observed, in the current study, resistance to non -beta lactam antibiotics was very high among ESBL- producers33. The observation is worrisome as treatment options for ESBL producing bacteria are expensive and most of the time not available in most health facilities in developing countries.

Conclusion

The magnitude of bacteriospermia and ESBL bacteriospermia is high among presumptive infertile men. We recommend that, infectology should be part of diagnosis and management of male infertility.

Limitations of the study

Due to limited funds, this study neither characterized other ESBL families (SHV and TEM) nor other CTX-M groups. Furthermore, we did not investigate other pathogens such as fungi and viruses which could have adverse impact on the quality and/or quantity of spermatozoa in semen of infertile men. Another limitation is, we lack data schistosomiasis screening which is endemic in this study setting and reported elsewhere to be associated with male infertility.
  21 in total

Review 1.  Antibiotic resistance in Enterobacteriaceae: mechanisms and clinical implications.

Authors:  Jon Iredell; Jeremy Brown; Kaitlin Tagg
Journal:  BMJ       Date:  2016-02-08

2.  Small studies: strengths and limitations.

Authors:  A Hackshaw
Journal:  Eur Respir J       Date:  2008-11       Impact factor: 16.671

Review 3.  Declining worldwide sperm counts: disproving a myth.

Authors:  Harry Fisch
Journal:  Urol Clin North Am       Date:  2008-05       Impact factor: 2.241

Review 4.  Phenotypic detection of extended-spectrum beta-lactamase production in Enterobacteriaceae: review and bench guide.

Authors:  L Drieux; F Brossier; W Sougakoff; V Jarlier
Journal:  Clin Microbiol Infect       Date:  2008-01       Impact factor: 8.067

5.  Predictors of positive blood culture and deaths among neonates with suspected neonatal sepsis in a tertiary hospital, Mwanza-Tanzania.

Authors:  Neema Kayange; Erasmus Kamugisha; Damas L Mwizamholya; Seni Jeremiah; Stephen E Mshana
Journal:  BMC Pediatr       Date:  2010-06-04       Impact factor: 2.125

Review 6.  World Health Organization reference values for human semen characteristics.

Authors:  Trevor G Cooper; Elizabeth Noonan; Sigrid von Eckardstein; Jacques Auger; H W Gordon Baker; Hermann M Behre; Trine B Haugen; Thinus Kruger; Christina Wang; Michael T Mbizvo; Kirsten M Vogelsong
Journal:  Hum Reprod Update       Date:  2009-11-24       Impact factor: 15.610

7.  Resistance to Cotrimoxazole and Other Antimicrobials among Isolates from HIV/AIDS and Non-HIV/AIDS Patients at Bugando Medical Centre, Mwanza, Tanzania.

Authors:  Karol J Marwa; Martha F Mushi; Eveline Konje; Paul E Alele; Jeremiah Kidola; Mariam M Mirambo
Journal:  AIDS Res Treat       Date:  2015-02-22

8.  Comparison of antimicrobial resistance patterns of ESBL and non ESBL bacterial isolates among patients with secondary peritonitis at Bugando Medical Centre, Mwanza - Tanzania.

Authors:  Jeremiah Seni; Enock Sweya; Amri Mabewa; Stephen E Mshana; Japhet M Gilyoma
Journal:  BMC Emerg Med       Date:  2016-10-21

9.  Predominance of Klebsiella pneumoniae ST14 carrying CTX-M-15 causing neonatal sepsis in Tanzania.

Authors:  Stephen E Mshana; Torsten Hain; Eugen Domann; Eligius F Lyamuya; Trinad Chakraborty; Can Imirzalioglu
Journal:  BMC Infect Dis       Date:  2013-10-07       Impact factor: 3.090

10.  Faecal carriage of CTX-M extended-spectrum beta-lactamase-producing Enterobacteriaceae among street children dwelling in Mwanza city, Tanzania.

Authors:  Nyambura Moremi; Heike Claus; Ulrich Vogel; Stephen E Mshana
Journal:  PLoS One       Date:  2017-09-12       Impact factor: 3.240

View more
  1 in total

1.  Extended Spectrum β-Lactamase Producing Lactose Fermenting Bacteria Colonizing Children with Human Immunodeficiency Virus, Sickle Cell Disease and Diabetes Mellitus in Mwanza City, Tanzania: A Cross-Sectional Study.

Authors:  Maria M Said; Delfina R Msanga; Conjester I Mtemisika; Vitus Silago; Mariam M Mirambo; Stephen E Mshana
Journal:  Trop Med Infect Dis       Date:  2022-07-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.